Search results
Puma Biotechnology Inc (PBYI) Reports Positive Net Income for Q4 and Full Year 2023
GuruFocus.com via Yahoo Finance· 3 months agoNet Income: PBYI reported a net income of $12.3 million in Q4 2023, a significant improvement from a...
Reasons to Add Puma (PBYI) Stock to Your Portfolio Right Now
Zacks via Yahoo Finance· 1 year agoPuma Biotechnology (PBYI), a top-ranked stock, has a promising development candidate, alisertib. Its...
PBYI or TECH: Which Is the Better Value Stock Right Now?
Zacks via Yahoo Finance· 6 months agoInvestors interested in Medical - Biomedical and Genetics stocks are likely familiar with Puma...
PBYI vs. VRTX: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance· 5 months agoInvestors interested in Medical - Biomedical and Genetics stocks are likely familiar with Puma...
Puma Biotech (PBYI) Is Attractively Priced Despite Fast-paced Momentum
Zacks via Yahoo Finance· 4 months agoPuma Biotech (PBYI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a...
PBYI vs. GMAB: Which Stock Should Value Investors Buy Now?
Zacks via Yahoo Finance· 2 years agoInvestors interested in stocks from the Medical - Biomedical and Genetics sector have probably...
Puma Biotech (PBYI)'s Technical Outlook is Bright After Key Golden Cross
Zacks via Yahoo Finance· 2 years agoFrom a technical perspective, Puma Biotechnology, Inc. (PBYI) is looking like an interesting pick,...
With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional...
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights Given the large stake in the stock by institutions, Puma Biotechnology's stock price...
Puma Biotech (PBYI) Q3 Earnings Top, Nerlynx Sales View Up
Zacks via Yahoo Finance· 2 years agoPuma Biotech (PBYI) beats earnings and revenue estimates for third-quarter 2022. It increases...
Puma Biotech (PBYI) Q3 Earnings Beat, Revenues Lag Estimates
Zacks via Yahoo Finance· 7 months agoPuma Biotechnology, Inc. PBYI reported third-quarter 2023 adjusted earnings of 17 cents per share,...